12 Common Infusions
Post on 10-Jan-2016
10 Views
Preview:
DESCRIPTION
Transcript
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 1/62
2 Infusions You
2 Infusions You
Need To Knoweed To Know
Mobile Intensive Care ParamedicMobile Intensive Care ParamedicSeriesSeries
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 2/62
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 3/62
Focus Statement
ocus Statement
Focus Statement: This module willFocus Statement: This module will
introduce the participant to the 12 mostintroduce the participant to the 12 most
common infusions encountered in CCT,common infusions encountered in CCT,their indications, contraindications,their indications, contraindications,
dosin reimens, and practical concerns!dosin reimens, and practical concerns!
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 4/62
Presentation Information
resentation Information
"ast revised #$%2#%#&"ast revised #$%2#%#&
For more information contact theFor more information contact the
education departmenteducation department 2#&'2&('2)(22#&'2&('2)(2
rcole@adaweb.net rcol
e@adaweb.net
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 5/62
Where this fits in the big
here this fits in the big
picture?icture?
This lecture discusses material in SectionThis lecture discusses material in Section
) of the) of the Idaho EMS Critical CareIdaho EMS Critical Care
Curricula GuideCurricula Guide Initial lecture on common infusions onl*!Initial lecture on common infusions onl*!
Man*, man*, more hours forthcominMan*, man*, more hours forthcomin
over ne+t few months!over ne+t few months!
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 6/62
Wh?
h?
The oal of dedicated critical care transportThe oal of dedicated critical care transport
and specialt* care transport is to continue theand specialt* care transport is to continue the
same level of care durin transport as thesame level of care durin transport as thepatient was receivin and ma* be receivin!patient was receivin and ma* be receivin!
This involves usin medication infusions out ofThis involves usin medication infusions out of
our comfort one!our comfort one!
Turnin them off -.T an option!Turnin them off -.T an option!
These meds are essential /nowlede of theThese meds are essential /nowlede of the
Mobile Intensive Care Paramedic 0MICPMobile Intensive Care Paramedic 0MICP
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 7/62
!ther important things"
ther important things"
ecreasin Medical 3rrorsecreasin Medical 3rrors
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 8/62
The #irt #o$en
he #irt #o$en
opamineopamine
obutamineobutamine
-itroprusside-itroprusside -or'epinephrine-or'epinephrine
-itro-itro
Standard compositionStandard composition 45MC Composition45MC Composition
InsulinInsulin
iltiaemiltiaem
6eparin6eparin
7IIb'IIIa Inhibitors7IIb'IIIa Inhibitors 5miodarone 5miodarone
PropofolPropofol
8etavase8etavase
9e also will discuss what I4 Fluid *ou ma* run
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 9/62
Some thoughts about
ome thoughts about
the %oute"&he %oute"&
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 10/62
What route ?
hat route ?
Central Central Ma* also be used for 6emod*namicMa* also be used for 6emod*namic
MonitorinMonitorin Man* t*pes:Man* t*pes:
PICC'inserted into antecubital vein andPICC'inserted into antecubital vein and
advanced into Superior 4ena Cavaadvanced into Superior 4ena Cava 3+amples: Triple lumen, 6ic/man,3+amples: Triple lumen, 6ic/man,
;roviac, and 7roshon;roviac, and 7roshon
P8.S:P8.S: 7ood for dru concentrates in fluid7ood for dru concentrates in fluid
restricted patientsrestricted patients 7ood for drus too irritant to be used7ood for drus too irritant to be used
peripherall*peripherall*
C.-S:C.-S: Slow and ris/* to ain accessSlow and ris/* to ain access needs e+perience < practiceneeds e+perience < practice Man* different t*pesMan* different t*pes Sterilit* a M=STSterilit* a M=ST 6epariniation6epariniation
Peripheral Peripheral P8.S:P8.S:
3as* and safer access3as* and safer access "are volumes"are volumes
Familiar routeFamiliar route C.-S:C.-S:
-ot suitable for all meds-ot suitable for all meds T*picall* not multi'lumenT*picall* not multi'lumen 3asier to displace3asier to displace InfiltrationInfiltration
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 11/62
Periphera' (ine Safet
eriphera' (ine Safet
I4s flow b* ravit* pressure, and the hiher theI4s flow b* ravit* pressure, and the hiher thesolution ba, the faster the I4 will infuse!solution ba, the faster the I4 will infuse! The averae heiht for an adult I4 solution ba is > feetThe averae heiht for an adult I4 solution ba is > feet
above heart level!above heart level! 9hen the ?heiht@ chanes, so does the infusion rate9hen the ?heiht@ chanes, so does the infusion rate
0unless on a pump!0unless on a pump!
Secondar* solution bas must han hiher thanSecondar* solution bas must han hiher than
the primar* ba to infuse first!the primar* ba to infuse first! 3ven when on a pump3ven when on a pump
Flush with confidenceA : SIS' saline, I4Flush with confidenceA : SIS' saline, I4med%infusion, salinemed%infusion, saline
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 12/62
Pigg )ac*?
igg )ac*?
Secondar* "inesSecondar* "ines 5ttach to primar* I4 at inBection ports 5ttach to primar* I4 at inBection ports
=sed primaril* to infuse meds or other I4 fluids=sed primaril* to infuse meds or other I4 fluidson intermittent basison intermittent basis if compatible with fluid onif com patible with fluid onthe primary linethe primary line
I4 pi*bac/s I4P;I4 pi*bac/s I4P;
I4P; hiher than primar* reater pressureI4P; hiher than primar* reater pressureand causes it to infuse firstand causes it to infuse first
9hen I4P; empt* primar* line will automaticall*9hen I4P; empt* primar* line will automaticall*resume its flowresume its flow
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 13/62
+entra' (ine Safet
entra' (ine Safet
Sterilit*Sterilit*
Medication Safet*Medication Safet*
S5S6 for Central lines' saline, 5dditive 0I4S5S6 for Central lines' saline, 5dditive 0I4
Med%infusion, saline, heparinMed%infusion, saline, heparin
8ecommend 5SPI85T3 on all central lines8ecommend 5SPI85T3 on all central lines
P8I.8 to flushin with saline as well!P8I.8 to flushin with saline as well!
Some lines have hih concentration heparin!Some lines have hih concentration heparin!
Someone else ma* not have flushed the line andSomeone else ma* not have flushed the line and
their ma* be I4 meds in it!their ma* be I4 meds in it!
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 14/62
S!,- T.!/0.TS 1)!/T
!,- T.!/0.TS 1)!/T
ST1YIN0 !/T !F
T1YIN0 !/T !F
T%!/)(-"&
%!/)(-"&
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 15/62
0-N-%1( +!N+-PTS0-N-%1( +!N+-PTS
Chec/ transfer order carefull* to be sure thatChec/ transfer order carefull* to be sure that
*ou are comfortable with all medications*ou are comfortable with all medications
ordered!ordered! ;e sure that order specifies:;e sure that order specifies:
Dosage informationDosage information
imes of administration !where applicable"imes of administration !where applicable"
Indications for changes or discontinuance.Indications for changes or discontinuance.
Eg. #itroglycerin dosage is often altered based onEg. #itroglycerin dosage is often altered based on
pain and$or %P. pain and$or %P.
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 16/62
5s/ the ph*sician or 8- to review 5s/ the ph*sician or 8- to review
medication if it is one that *ou are notmedication if it is one that *ou are not
familiar with!familiar with!
iscuss potential adverse reactions andiscuss potential adverse reactions and
how to deal with them!how to deal with them!
=se resources to double chec/=se resources to double chec/
ru 8eferencesru 8eferences
0-N-%1( +!N+-PTS0-N-%1( +!N+-PTS
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 17/62
0-N-%1( +!N+-PTS0-N-%1( +!N+-PTS
etermine how lon it willetermine how lon it willta/e to reach receivin facilit*ta/e to reach receivin facilit*
and calculate the amount ofand calculate the amount of
the dru *ou will need tothe dru *ou will need toreach *our destination!reach *our destination!
&llow for unforeseen delays. &llow for unforeseen delays.
%oy Scout 'irewood (ule%oy Scout 'irewood (ule
) times what you thin* you will) times what you thin* you will
need+ and then some more.need+ and then some more.
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 18/62
Chec/ to be sure that *ou have theChec/ to be sure that *ou have the
riht dru and the riht concentration!riht dru and the riht concentration! Ma/e sure it is hoo/ed up to the rihtMa/e sure it is hoo/ed up to the riht
pump channel!pump channel!
0-N-%1( +!N+-PTS0-N-%1( +!N+-PTS
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 19/62
Consider usin the hospitals I4 PumpConsider usin the hospitals I4 Pump 7ood for short transfers!7ood for short transfers!
"imits chance of errors or runawa* lines"imits chance of errors or runawa* linesdurin transfers!durin transfers!
;e sure *ou able to troubleshoot potential;e sure *ou able to troubleshoot potentialproblems with the pumpproblems with the pump
Chec/ I4 site for patenc*, redness, etc!Chec/ I4 site for patenc*, redness, etc! Poor "ine ManaementPoor "ine Manaement will will causecause
problems, even on short transfers!problems, even on short transfers!
0-N-%1( +!N+-PTS0-N-%1( +!N+-PTS
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 20/62
;e sure to have a dru reference boo/;e sure to have a dru reference boo/
available in *our ambulanceavailable in *our ambulance
8eview dru reference for detailed information8eview dru reference for detailed informationabout the dru!about the dru!
(e,iew side effects+ ad,erse reactions+ dosing+(e,iew side effects+ ad,erse reactions+ dosing+
interactions+ etc.interactions+ etc.
S(-#G/ S(-#G/ consider callin medical control ifconsider callin medical control ifit becomes necessar* to administer anotherit becomes necessar* to administer another
dru to ascertain possible interaction problemsdru to ascertain possible interaction problems
0-N-%1( +!N+-PTS0-N-%1( +!N+-PTS
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 21/62
Some thoughts about I
ome thoughts about I
f'uid
'uid
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 22/62
Tpes of I so'ution
pes of I so'ution
$ classes of I4 sol$ classes of I4 sol
Cr*stalloids e+trose, saline, "8Cr*stalloids e+trose, saline, "8
Colloids volume e+panders such asColloids volume e+panders such ase+tran, 6etastarche+tran, 6etastarch
;ld < ;ld products whole bld,pac/ed;ld < ;ld products whole bld,pac/ed
8;Cs, plasma < albumin8;Cs, plasma < albumin
"ipids fat emulsion sol indicated if on I4s"ipids fat emulsion sol indicated if on I4s
more than D da*smore than D da*s
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 23/62
What I f'uid ?
hat I f'uid ?
Crystalloid0Cr ystalloid0
P8.S:P8.S: Most familiar Most familiar
CheapCheap
C.-S:C.-S: Ma* need lare volumesMa* need lare volumes
8elativel* slow increase in8elativel* slow increase in
C4PC4P
9ill move out of vascular9ill move out of vascular
spacespace
.ver 2## diff I4 fluids bein.ver 2## diff I4 fluids bein
manufacturedmanufactured
Colloid0Colloid0
P8.S:P8.S: 8apid increase in C4P8apid increase in C4P
Small volumesSmall volumes 9ater redistribution out of9ater redistribution out of
tissuestissues
5E5: Colloid Pullin Power 5E5: Colloid Pullin Power
C.-S:C.-S: .nl* for Criticall* ill.nl* for Criticall* ill
3+pensive3+pensive
9ater redistribution out of9ater redistribution out of
tissuestissues
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 24/62
F'uid ba'ance
'uid ba'ance
5 simple uestion of input eual to output 5 simple uestion of input eual to output 7oal: 1ml%/%hr urine output7oal: 1ml%/%hr urine output 5 comple+ balance of forces to achieve a urine output 5 comple+ balance of forces to achieve a urine output
of about 1ml%/%hr 0assumin normal renal functionof about 1ml%/%hr 0assumin normal renal functionwithout causin heart failure, pulmonar* or peripheralwithout causin heart failure, pulmonar* or peripheraledemaedema
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 25/62
The #rugs"&
he #rugs"&
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 26/62
#opamine
opamine
I4 Infusions 0Titrate to 3ffectI4 Infusions 0Titrate to 3ffect "ow ose"ow ose “Renal Dose" “Renal Dose"
1 to D G%/ per minute1 to D G%/ per minute
Moderate oseModerate ose “Cardiac Dose" “Cardiac Dose" D to 1# G%/ per minuteD to 1# G%/ per minute
6ih ose6ih ose “Vasopressor Dose" “Vasopressor Dose" 1# to 2# G%/ per minute1# to 2# G%/ per minute
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 27/62
#opamine
opamine
PrecautionsPrecautions (Watch Out!)(Watch Out!)
Ma* use in patients with h*povolemia but onl* afterMa* use in patients with h*povolemia but onl* aftervolume replacementvolume replacement
Ma* cause tach*arrh*thmias, e+cessiveMa* cause tach*arrh*thmias, e+cessivevasoconstrictionvasoconstriction
DO NOT DO NOT mi+ with sodium bicarbonatemi+ with sodium bicarbonate
9atch for s%s for fluid overload and h*pertension!9atch for s%s for fluid overload and h*pertension!
oses hiher than 2#%mc%/ ma* compromiseoses hiher than 2#%mc%/ ma* compromiseperipheral circulationperipheral circulation
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 28/62
#obutamine
obutamine
Consider for pump problems 0conestive heart failure,Consider for pump problems 0conestive heart failure,pulmonar* conestion with s*stolic blood pressurepulmonar* conestion with s*stolic blood pressureof (# to 1## mm 6 and no sins of shoc/of (# to 1## mm 6 and no sins of shoc/
Increases Inotrop*Increases Inotrop* osinosin
=sual infusion rate is 2 to 2# G%/ per minute,=sual infusion rate is 2 to 2# G%/ per minute, 5bsolute ma+ of $# mc/%/%min 5bsolute ma+ of $# mc/%/%min
Titrate so heart rate does not increase b* more than 1#H ofTitrate so heart rate does not increase b* more than 1#H of
baselinebaseline 6emod*namic monitorin is recommended for optimal use6emod*namic monitorin is recommended for optimal use
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 29/62
#obutamine
obutamine
PrecautionsPrecautions
5void when s*stolic blood pressure 1## 5void when s*stolic blood pressure 1##
mm 6 with sins of shoc/, considermm 6 with sins of shoc/, considerdopamine instead!dopamine instead!
Ma* cause tach*arrh*thmiasMa* cause tach*arrh*thmias
. -.T mi+ with sodium bicarbonate. -.T mi+ with sodium bicarbonate
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 30/62
Norepinephrine
orepinephrine
Brand Name:Brand Name: "evophed"evophedGeneric Name:Generic Name: -orepinephrine ;itartrate-orepinephrine ;itartrate
IndicationsIndications
For severe cardioenic shoc/ and hemod*namicFor severe cardioenic shoc/ and hemod*namic
sinificant h*potension 0s*stolic blood pressure (#sinificant h*potension 0s*stolic blood pressure (#
mm%6 with low total peripheral resistancemm%6 with low total peripheral resistance
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 31/62
Norepinephrine
orepinephrine
Man* 4arious infusions in use!Man* 4arious infusions in use!
T*picall* 1 m in 2D# cc or 2 m in D## ccT*picall* 1 m in 2D# cc or 2 m in D## cc
DosageDosage 0initial: & to 12 mc%min 'titrate to ;P0initial: & to 12 mc%min 'titrate to ;P0=sual taret: S;:&#'1## or M5PJ&#! =sual0=sual taret: S;:&#'1## or M5PJ&#! =sualmaintenance: 2 to $ mc%min!maintenance: 2 to $ mc%min! -ote: doses as hih as #!D to 1!D mc%/%min for 1'-ote: doses as hih as #!D to 1!D mc%/%min for 1'
1#da*s have been used in septic shoc/!1#da*s have been used in septic shoc/!
Poison%dru'induced h*potension 0i!e! TC5sPoison%dru'induced h*potension 0i!e! TC5sma* reuire hiher doses to achievema* reuire hiher doses to achieveadeuate perfusionadeuate perfusion
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 32/62
Norepinephrine
orepinephrine
PrecautionsPrecautions (Watch Out!)(Watch Out!) Increases m*ocardial o+*en reuirementsIncreases m*ocardial o+*en reuirements Good vasculature required (i.e. Central or large peripheral)Good vasculature required (i.e. Central or large peripheral)
DO NOT DO NOT
administer is same I4 line as al/aline infusions 0i!e! ;icarbadminister is same I4 line as al/aline infusions 0i!e! ;icarb
Ma* induce arrh*thmiasMa* induce arrh*thmias
3+travasation causes tissue necrosis3+travasation causes tissue necrosis
Should be administered in de+trose containin solutions 0i!e!Should be administered in de+trose containin solutions 0i!e!D9 or D%#!$DH -S!D9 or D%#!$DH -S!
These de+trose containin fluids are protection aainst sinificantThese de+trose containin fluids are protection aainst sinificantloss of potenc* due to o+idation!loss of potenc* due to o+idation!
Administration in saline solution alone is not recommended.Administration in saline solution alone is not recommended.
;lood products should be administered in separate line!;lood products should be administered in separate line!
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 33/62
Sodium Nitroprusside
odium Nitroprusside
3Nitropress4
Nitropress4
Sodium nitroprusside is indicated for theSodium nitroprusside is indicated for the
immediate reduction of blood pressure ofimmediate reduction of blood pressure of
patients in hypertensive crises.patients in hypertensive crises.
Sodium nitroprusside is also indicated forSodium nitroprusside is also indicated for
producing controlled hypotension in orderproducing controlled hypotension in order
to reduce bleeding during surgery.to reduce bleeding during surgery.
Sodium nitroprusside is also indicated forSodium nitroprusside is also indicated forthe treatment of acute congestive heartthe treatment of acute congestive heart
failure.failure.
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 34/62
Sodium Nitroprusside
odium Nitroprusside
Initial 0#!> G%/%minInitial 0#!> G%/%min Titrated to 1#Titrated to 1#
G%/%min ma+G%/%min ma+
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 35/62
Sodium Nitroprusside
odium Nitroprusside
PrecautionsPrecautions (Watch Out!)(Watch Out!) -itroprusside must be reconstituted for each use! It is ood for 2$ hours-itroprusside must be reconstituted for each use! It is ood for 2$ hours
afterward!afterward! The diluted solution should be protected from liht! It is not necessar* to coverThe diluted solution should be protected from liht! It is not necessar* to cover
the infusion drip chamber or the tubin!the infusion drip chamber or the tubin!
-itroprusside can be deactivated inadvertentl* b* contaminates! -ormal-itroprusside can be deactivated inadvertentl* b* contaminates! -ormal-itroprusside is a faint brownish color!-itroprusside is a faint brownish color! Contaminated nitroprusside will often be blue, reen, or red, much brihter colorsContaminated nitroprusside will often be blue, reen, or red, much brihter colors Particulate ma* be visible!Particulate ma* be visible! iscard if this is noted!iscard if this is noted!
o not mi+ with an* other drus in same line!o not mi+ with an* other drus in same line! Severe 6*potension ma* develop even at normal rates!Severe 6*potension ma* develop even at normal rates!
8is/ of C*anide To+icit*8is/ of C*anide To+icit* Total dose K D## mc%/ ! 7reater ris/ with impaired renal functionTotal dose K D## mc%/ ! 7reater ris/ with impaired renal function 7reater than 2 mc%/%min7reater than 2 mc%/%min Treat with Sodium Thiosulfate 0increased 6*potension ris/Treat with Sodium Thiosulfate 0increased 6*potension ris/
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 36/62
Nitro5 Standard
itro5 Standard
composition6s4
omposition6s4
7lass ;ottles7lass ;ottles
Standard Half-strength concentrationStandard Half-strength concentration
!"" mcg#ml$ %ost common at !"" mcg#ml$ %ost common at !RC#!C !RC#!C &' mg#&'" ml( or '" mg#'"" ml&' mg#&'" ml( or '" mg#'"" ml
Standard )ull-strength concentrationStandard )ull-strength concentration
%ost common used at%ost common used at $RC#$%C $RC#$%C
&"" mcg#ml$&"" mcg#ml$ '" mg#&'" ml'" mg#&'" ml
Multiple other wa*s to mi+L!!Multiple other wa*s to mi+L!!
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 37/62
Nitro5 1,+
itro5 1,+
+omposition
omposition
;a;a #- & %-E #- & %-E
># M7%D## CC># M7%D## CC
1 MC7%M"1 MC7%M"
C.-C3-T85TI.-C.-C3-T85TI.-
1 MCG$MI# 2 11 MCG$MI# 2 1
CC$3-4( CC$3-4( E5ample+ you want toE5ample+ you want to
run #G at )6run #G at )6
mcg$min+mcg$min+ R&N 'T $TR&N 'T $T
G#*O&R. G#*O&R.
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 38/62
Nitro
itro
PrecautionsPrecautions (Watch Out!)(Watch Out!)
CON+'R CONC%NTR$T'ON CON+'R CONC%NTR$T'ON ;eware 8unawa* lines;eware 8unawa* lines 5 separate line should be used when possible, or at 5 separate line should be used when possible, or at
least pi*bac/ed!least pi*bac/ed! 5 patient with a nitro drip reuires blood pressure 5 patient with a nitro drip reuires blood pressure
monitorin with either non'invasive blood pressuremonitorin with either non'invasive blood pressureor arterial line, at least ever* five 0D minutes untilor arterial line, at least ever* five 0D minutes until
stabilied!stabilied! The patient should have continuous 3E7 monitorinThe patient should have continuous 3E7 monitorin
while receivin the dru!while receivin the dru!
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 39/62
Insu'in
nsu'in
Commonl* used for diabetic and nonCommonl* used for diabetic and non
diabetic patients in the Critical Carediabetic patients in the Critical Care
settinsettin Ma* be included in TP- mi+tures! If it isMa* be included in TP- mi+tures! If it is
not, it is administered as well!not, it is administered as well!
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 40/62
Tpica' Insu'in Infusion
pica' Insu'in Infusion
'nsulin in,usions are institution speci,ic.'nsulin in,usions are institution speci,ic. 5n initial bolus is iven per M order, t*picall* up to 1# units reular! 5n initial bolus is iven per M order, t*picall* up to 1# units reular! 5 maintenance infusion was then started at 2 units%hr ! 5 maintenance infusion was then started at 2 units%hr !
If follow up ;7 remains at reater than >## m%dl, or did not decrease b* 2D m%d, thenIf follow up ;7 remains at reater than >## m%dl, or did not decrease b* 2D m%d, theninsulin is increased b* 2 u%hour insulin is increased b* 2 u%hour
If the patientNs blood lucose concentration decreased b* 2D m%d" but 1## m%d"If the patientNs blood lucose concentration decreased b* 2D m%d" but 1## m%d"from the previous blood lucose value, the infusion rate was not chanedfrom the previous blood lucose value, the infusion rate was not chaned If the ;7 drops b* 1## m%d", then infusion decreased in half and rechec/ed in oneIf the ;7 drops b* 1## m%d", then infusion decreased in half and rechec/ed in one
hour!hour! 5fter the tareted ;7 is achieved, if the blood lucose level 5fter the tareted ;7 is achieved, if the blood lucose level continued to decrease overcontinued to decrease over
three consecutive measurements(three consecutive measurements( the infusion rate was decreased b* #!D '1 unit%hr,the infusion rate was decreased b* #!D '1 unit%hr, If blood lucose concentrations fell below &# m%d at an* time, the infusion was stopped,If blood lucose concentrations fell below &# m%d at an* time, the infusion was stopped,
and blood lucose levels were rechec/ed hourl* until it returns to &# m%d" or reater!and blood lucose levels were rechec/ed hourl* until it returns to &# m%d" or reater! .nce the blood lucose is &# m%d", the infusion was restarted at D#H of the previous.nce the blood lucose is &# m%d", the infusion was restarted at D#H of the previous
rate!rate! If the blood lucose concentration falls below O# m%d", the infusion was discontinued 0ifIf the blood lucose concentration falls below O# m%d", the infusion was discontinued 0if
not alread* stopped and D#H de+trose inBection was iven!not alread* stopped and D#H de+trose inBection was iven!
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 41/62
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 42/62
Insu'in
nsu'in
PrecautionsPrecautions (Watch Out!)(Watch Out!) 5s/ for a cop* of the institutional protocol 0or the 5s/ for a cop* of the institutional protocol 0or the
one the M wrote for reference!one the M wrote for reference!
5s/ what the oal ;7 is for this patient! 5s/ what the oal ;7 is for this patient! T*picall* between 1## and 1># m%dl but ma* be patientT*picall* between 1## and 1># m%dl but ma* be patient
specific!specific! 9hat is the crisis levelA 0t*picall* &# m%dl9hat is the crisis levelA 0t*picall* &# m%dl
Chec/ lucose atChec/ lucose at
beinnin of transport,beinnin of transport, ># minutes into transport># minutes into transport 3ver* O# minutes unless drops below 1## m%dl, then3ver* O# minutes unless drops below 1## m%dl, then
ever* 1D minutes until normalied!ever* 1D minutes until normalied!
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 43/62
#i'tia$em
i'tia$em
Must be reconstituted and used with inMust be reconstituted and used with in
2$ hours! 0or refrierated used with in >#2$ hours! 0or refrierated used with in >#
da*sda*s ose:ose:
Initial bolus as ordered b* M, followed b* DInitial bolus as ordered b* M, followed b* D
m%hour, titrated to 1D m%hour ma+!m%hour, titrated to 1D m%hour ma+!
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 44/62
#i'tia$em
i'tia$em
PrecautionsPrecautions (Watch Out!)(Watch Out!)
Most common side effect isMost common side effect is
HYPOTENSION (3-5% of patients)HYPOTENSION (3-5% of patients)
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 45/62
.eparin
eparin
*sed to prevent e+tension of e+isting clot or*sed to prevent e+tension of e+isting clot orformation of ne, blood clotsformation of ne, blood clots
Does not dissolve e+isting clotsDoes not dissolve e+isting clots
atients may be on these drugs for e+tendedatients may be on these drugs for e+tendedperiods of timeperiods of time
%ost commonly used anticoagulants:%ost commonly used anticoagulants:
6eparin6eparin
"oveno+ 03no+aparin 5E5 ?"ow Molecular"oveno+ 03no+aparin 5E5 ?"ow Molecular
9eiht 6eparin@ 0S9eiht 6eparin@ 0S
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 46/62
.eparin
eparin
4arious protocols' facilit*, ph*sician, patient,4arious protocols' facilit*, ph*sician, patient,and situation dependant!and situation dependant! 8efer to institutional written order!8efer to institutional written order!
', see-s unusual con,ir- ith D.', see-s unusual con,ir- ith D.
Common osinCommon osin Initial bolus O# I=%/Initial bolus O# I=%/
Ma+imum bolus: $### I=Ma+imum bolus: $### I=
.ften forotten.ften forotten
Continue at 12 I=%/%hr 0ma+imum 1### I=%hr forContinue at 12 I=%/%hr 0ma+imum 1### I=%hr forpatients (# /, round to the nearest D# I=patients (# /, round to the nearest D# I=
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 47/62
PrecautionsPrecautions (Watch Out!)(Watch Out!) ::
(un &way I78s(un &way I78s
Signs of bleeding+ either internallySigns of bleeding+ either internally
or e5ternally or e5ternally
Monitor ,itals fre9uently Monitor ,itals fre9uently
Signs and symptoms of shoc* Signs and symptoms of shoc*
<ered le,el of consciousness <ered le,el of consciousness
.eparin
eparin
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 48/62
0(Y+!P%!T-IN IIb7IIIa
(Y+!P%!T-IN IIb7IIIa
Inhibitors
nhibitors
Indications:Indications:
Inhibit the interin l*coprotein IIb%IIIaInhibit the interin l*coprotein IIb%IIIa
receptor in the membrane of platelets,receptor in the membrane of platelets,inhibitin platelet areationinhibitin platelet areation
Indicated for 5cute Coronar* S*ndromesIndicated for 5cute Coronar* S*ndromes
ithoutithout ST sement elevationST sement elevation
+requentl/ used ith *eparin+requentl/ used ith *eparin
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 49/62
0(Y+!P%!T-IN0(Y+!P%!T-IN
IIb8IIa P'ate'et InhibitorsIIb8IIa P'ate'et Inhibitors
Three most common 7IIb%IIIa Inhibitors are:Three most common 7IIb%IIIa Inhibitors are:
5bci+imab 08eoPro 5bci+imab 08eoPro
3ptifibitide 0Interilin3ptifibitide 0Interilin
Tirofiban 05rastatTirofiban 05rastat
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 50/62
5bci+imab 08eoPro 5bci+imab 08eoPro
-on wave MI or unstable anina with-on wave MI or unstable anina with
planned PCI within 2$ hoursplanned PCI within 2$ hours
Must use with heparinMust use with heparin
;inds irreversibl* with platelets;inds irreversibl* with platelets
Platelet function recover* reuires $&Platelet function recover* reuires $&
hourshours
0(Y+!P%!T-IN0(Y+!P%!T-IN
IIb8IIa P'ate'et InhibitorsIIb8IIa P'ate'et Inhibitors
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 51/62
0(Y+!P%!T-IN0(Y+!P%!T-IN
IIb8IIa P'ate'et InhibitorsIIb8IIa P'ate'et Inhibitors
3ptifibitide 0Interilin3ptifibitide 0Interilin
-on wave MI, unstable anina manaed-on wave MI, unstable anina manaed
medicall*, and unstable anina % -on wave MImedicall*, and unstable anina % -on wave MI
patients underoin PCIpatients underoin PCI
Platelet function recovers within $ to & hours afterPlatelet function recovers within $ to & hours after
discontinuationdiscontinuation
5dministered with 5S5 0or clopidorel and 6eparin! 5dministered with 5S5 0or clopidorel and 6eparin!
osinosin ;olus 1&# G%/ over 1 to 2 minutes;olus 1&# G%/ over 1 to 2 minutes
I4 Infusion 2 G%/%minuteI4 Infusion 2 G%/%minute
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 52/62
0(Y+!P%!T-IN0(Y+!P%!T-IN
IIb8IIa P'ate'et InhibitorsIIb8IIa P'ate'et Inhibitors
Tirofiban 05rastatTirofiban 05rastat
-on wave MI, unstable anina manaed-on wave MI, unstable anina manaed
medicall*, and unstable anina % -on wave MImedicall*, and unstable anina % -on wave MI
patients underoin PCIpatients underoin PCI
Platelet function recovers within $ to & hoursPlatelet function recovers within $ to & hours
after discontinuationafter discontinuation
oseose ;olus #!$ G%/ and minute for ># minutes!;olus #!$ G%/ and minute for ># minutes!
Followed b* infusion at #!1 G%/ %minute!Followed b* infusion at #!1 G%/ %minute!
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 53/62
0(Y+!P%!T-IN0(Y+!P%!T-IN
IIb8IIa P'ate'et InhibitorsIIb8IIa P'ate'et Inhibitors
oute of Administration:oute of Administration:
I7 infusion only I7 infusion only
Small %ottlesSmall %ottles
Can lose alot of the drugCan lose alot of the drug
flushing the tubing+ be carefulflushing the tubing+ be carefulnot to waste.not to waste.
0 +! !
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 54/62
/hat to ,atch for during transport:/hat to ,atch for during transport:
3/PE(E#SI-# !increased bleeding3/PE(E#SI-# !increased bleeding
ris*"ris*"
&ny signs of bleeding &ny signs of bleeding
Signs and symptoms of shoc* Signs and symptoms of shoc*
Changes in le,el of consciousnessChanges in le,el of consciousness
0(Y+!P%!T-IN0(Y+!P%!T-IN
IIb8IIa P'ate'et InhibitorsIIb8IIa P'ate'et Inhibitors
0(Y+!P%!T-IN
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 55/62
otential interventions in cases ofotential interventions in cases of
adverse or allergic reactions:adverse or aller gic reactions:
Control any e5ternal bleeding Control any e5ternal bleeding reat for shoc* as needed reat for shoc* as needed
Contact -MC for options of discontinuingContact -MC for options of discontinuing
drug+ altering dose or di,ersiondrug+ altering dose or di,ersion
In cases of suspected bleeding+ the pro,iderIn cases of suspected bleeding+ the pro,ider
may also ha,e to D$C heparin if it is alsomay also ha,e to D$C heparin if it is also
being administered being administered
0(Y+!P%!T-IN0(Y+!P%!T-IN
IIb8IIa P'ate'et InhibitorsIIb8IIa P'ate'et Inhibitors
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 56/62
1miodarone
miodarone
ifference between ;."=S infusion andifference between ;."=S infusion and2$ hour infusion2$ hour infusion
;olus infusion;olus infusion 1D# m%1## cc1D# m%1## cc
1D# m bolus over 1# min1D# m bolus over 1# min
Maintenance InfusionMaintenance Infusion $D#m %2D#cc 1!& m%ml$D#m %2D#cc 1!& m%ml
1 m%min for 11 m%min for 1stst O hoursO hours
Then #!D m%min for remainin 2$ hoursThen #!D m%min for remainin 2$ hours
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 57/62
1miodarone
miodarone
PrecautionsPrecautions (Watch Out!)(Watch Out!)
6*potension6*potension
9idened T interval9idened T interval
CanQt use if TC5 overdose or ProcainimideCanQt use if TC5 overdose or Procainimide
has been used!has been used!
CanQt use Procainimide for refractor* ectop*CanQt use Procainimide for refractor* ectop*
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 58/62
Propofo'
ropofo'
Fat suspension 0larerFat suspension 0larer
vein if possiblevein if possible
StandardStandard
concentration 1#concentration 1#
m%mlm%ml
osesoses
D'D# mc%/%minD'D# mc%/%mintitrated in D mctitrated in D mc
increments!increments!
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 59/62
Propofo'
ropofo'
PrecautionsPrecautions (Watch Out!)(Watch Out!)
6RP.T3-SI.- is biest concern!6RP.T3-SI.- is biest concern!
6*per/alemia6*per/alemia
Metabolic 5cidosisMetabolic 5cidosis
Most problems common when usin hih'Most problems common when usin hih'
dose 0KD m%/%h and lon'term 0K$& hdose 0KD m%/%h and lon'term 0K$& h
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 60/62
%eta9ase
eta9ase
8apid , eas* to use thrombol*tic8apid , eas* to use thrombol*tic
First bolus of 1# =nitsFirst bolus of 1# =nits
># minutes later 2># minutes later 2ndnd bolus of 1# units is ivenbolus of 1# units is iven
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 61/62
%eta9ase
eta9ase
PrecautionsPrecautions (Watch Out!)(Watch Out!)
Heparin and etavase0 are incompatibleHeparin and etavase0 are incompatible
,hen combined in solution. Do not,hen combined in solution. Do notadminister heparin and etavase0administer heparin and etavase0
simultaneously in the same intravenoussimultaneously in the same intravenous
line.line.
BleedingBleeding
7/18/2019 12 Common Infusions
http://slidepdf.com/reader/full/12-common-infusions 62/62
Summar
ummar
9atch for run awa* I4Qs, especiall*9atch for run awa* I4Qs, especiall*
durin chaneoversdurin chaneovers
5"95RS .=;"3 C63CE 5"95RS .=;"3 C63CEC.-C3-T85TI.-SC.-C3-T85TI.-S
ouble chec/ M orders!ouble chec/ M orders!
onQt mi+ infusions prior to confirminonQt mi+ infusions prior to confirmincompatabilit*!compatabilit*!
top related